🔎 Trials Near Me

Akèy › Kansè aparèy respiratwa › Virginia

Etid klinik pou Kansè aparèy respiratwa nan Virginia

3 etid pou Kansè aparèy respiratwa ap chèche patisipan nan sit nan Virginia.

Vil nan Virginia

Tèks ofisyèl etid la (Anglè)

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • NEXT Oncology Virginia, Fairfax
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • University of Virginia Health System, Charlottesville
  • USO - Virginia Cancer Specialists, Fairfax
  • VCU Health Adult Outpatient Pavillion, Richmond
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

  • University of Virginia, Charlottesville
  • Virginia Cancer Specialists, Fairfax
  • Shenandoah Oncology, P.C., Winchester
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07185997

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.